STANIFORTH, JOHN,MORTON, DAVID,TOBYN, MICHAEL,EASON, STEPHEN,HARMER, QUENTIN,GANDERTON, DAVID
申请号：
CA2522158
公开号：
CA2522158C
申请日:
2004.04.14
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention relates to enhancing the dosing efficiency of apomorphine drypowderformulations administered by pulmonary inhalation. This is achieved by a drypowder formulation forpulmonary administration comprising active particles mixed with carrierparticles, wherein said activeparticles have a surface having an amount of force control agent thereon andsaid carrier particles have asurface having an amount of force control agent thereon.
